Graeme Rocker

Graeme Rocker

Auto-generated profile, based on publicly available information

Graeme Rocker

Division of Respirology, QEII Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2009 in Thorax
Verified
Journal Article
Open access
PDF file
GRG Rocker
G Rocker
RHR Horton
R Horton
DCD Currow
D Currow
DGDonna Goodridge
Donna Goodridge
JYJ Young
J Young
SBS Booth
S Booth
Chronic obstructive pulmonary disease (COPD) will be the third leading cause of death worldwide by 2020. The burdens of this increasingly prevalent illness borne by patients, their family caregivers and the healthcare system are substantial. Dyspnoea as the predominant symptom becomes increasingly difficult to palliate as COPD progresses through advanced stages and, for 50% of patients, can become refractory to conventional treatment. This narrative review focuses on the potential role for carefully initiated and titrated opioids in the management of dyspnoea for patients with advanced COPD who are not yet in a terminal stage, yet struggle with symptoms that reflect underlying mechanisms of dyspnoea that lend themselves to this approach. The many barriers that currently exist to the provision of opioids in this setting are addressed, and recommendations are provided for an approach that should engender confidence among patients, their caregivers and the physicians who treat them.

1 June 2007 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
GRGraeme M. Rocker
Graeme M. Rocker
TSTasnim Sinuff
Tasnim Sinuff
RHRobert Horton
Robert Horton
PHPaul Hernandez
Paul Hernandez
By the year 2020, chronic obstructive pulmonary disease (COPD) will be the third leading cause of death globally. While there have been consistent calls for increased palliative care involvement in the care of patients with advanced COPD, these calls should be based on empirical evidence that such an approach improves the symptom burden and poor quality of life associated with advanced COPD. Rather than reviewing the traditional treatments of airflow obstruction and palliative measures familiar to the palliative care community, we will focus on some novel approaches to the management of patients with advanced COPD from the perspective of clinicians involved in end of life care provision and research. By combining the clinical and research skills of pulmonologists and palliative medicine specialists we can advance the care of patients with this progressive and incurable disease.

1 June 2004 in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Verified
Journal Article
Closed access
PDF file
GRGraeme M. Rocker
Graeme M. Rocker
DHDaren K. Heyland
Daren K. Heyland
DCDeborah J. Cook
Deborah J. Cook
PDPeter M. Dodek
Peter M. Dodek
DKDemetrios J. Kutsogiannis
Demetrios J. Kutsogiannis
COChristopher J. O’cAllaghan
Christopher J. O’cAllaghan

1 June 2004 in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Verified
Journal Article
Closed access
PDF file
RHRichard I. Hall
Richard I. Hall
GRGraeme M. Rocker
Graeme M. Rocker
DMDawnelda Murray
Dawnelda Murray

1 September 2015 in Chest
Verified
Journal Article
Closed access
PDF file
GRGraeme M. Rocker
Graeme M. Rocker
ASA. Catherine Simpson
A. Catherine Simpson
RHRobert Horton
Robert Horton

1 January 2008 in Canadian Respiratory Journal
Verified
Journal Article
Open access
PDF file
GRGraeme M Rocker
Graeme M Rocker
PDPeter M Dodek
Peter M Dodek
DHDaren K Heyland
Daren K Heyland
FNFor The Canadian Researchers At The End Of Life Network
For The Canadian Researchers At The End Of Life Network
BACKGROUND: Understanding patients’ needs and perspectives is fundamental to improving end‐of‐life (EOL) care. However, little is known of what quality care means to patients who have advanced lung disease.OBJECTIVES: To describe ratings of importance and satisfaction with elements of EOL care, informational needs, decision‐making preferences, obstacles to a preferred location of death, clinical outcomes, and health care use before and during an index hospital admission for patients who have advanced chronic obstructive pulmonary disease (COPD).METHODS: A questionnaire with regard to quality EOL care was administered to patients older than 55 years of age who had advanced medical disease in five Canadian teaching hospitals.RESULTS: For 118 hospitalized patients who had advanced COPD, the following items were rated as extremely important for EOL care: not being kept alive on life support when there is little hope for meaningful recovery (54.9% of respondents), symptom relief (46.6%), provision of care and health services after discharge (40.0%), trust and confidence in physicians (39.7%), and not being a burden on caregivers (39.6%). Compared with patients who had metastatic cancer, patients with COPD had lower (P<0.05) satisfaction with care, interest in information about prognosis, cardiopulmonary resuscitation or mechanical ventilation, and referral rates to palliative care, whereas use of acute care services was higher (P<0.05) for patients who had advanced COPD.CONCLUSION: Canadian patients who have advanced COPD identify several priorities for improving care. Avoidance of prolonged or unwanted life support requires more effective communication, decision making and goal setting. Patients also deserve better symptom control and postdischarge strategies to minimize perceived burdens on caregivers, emergency room visits and hospital admissions.